BES-19318-40688
4 vaccinations
5 coded responses
49 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 981 / WA
- Registered
- 2020-12-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-29
Registered in v-safe
-
2020-12-29
Dose 1 — Moderna
- 2020-12-29
-
2020-12-30
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2020-12-31
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2020-12-31
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-05
-
2021-01-12
Survey response — day 14, dose 1MedDRA: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth — Feeling: GoodFree text: Injection site swelled again with redness, warmth, and itching for 2 daysMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-19
-
2021-01-26
Dose 2 — Moderna
- 2021-01-26
-
2021-01-27
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-28
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-29
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-30
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-09
- 2021-02-17
- 2021-02-23
- 2021-03-02
- 2021-03-09
- 2021-04-27
-
2021-07-28
Survey response — 6 months, dose 2MedDRA: Abortion spontaneous — Feeling: GoodFree text: Miscarriage (early/chemical)MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-21
Dose 3 — Moderna
- 2021-08-21
-
2021-08-22
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-08-23
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-08-24
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-08-25
- 2021-08-27
- 2021-08-28
- 2021-09-04
- 2021-09-11
- 2021-09-18
-
2021-09-25
Survey response — day 35, dose 3MedDRA: Myalgia — Feeling: FairFree text: Generalized myalgiasMedDRA releases: 2024-11 · check-in free text available
-
2021-10-03
Survey response — day 42, dose 3MedDRA: Fatigue, Myalgia — Feeling: FairFree text: Fatigue, evening muscle achesMedDRA releases: 2024-11 · check-in free text available
- 2021-11-20
-
2022-02-10
Dose 4 — Moderna
-
2022-02-11
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-02-13
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-02-14
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Headache, Muscle or body achesAdult check-in
- 2022-02-15
- 2022-02-16
- 2022-02-18
- 2022-02-26
- 2022-03-03
- 2022-03-13
- 2022-03-18
-
2022-05-17
Survey response — 3 months, dose 4MedDRA: Chills, Cough, Headache, Oropharyngeal pain, Pyrexia, SARS-CoV-2 test positive — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Recently tested positive for Covid19, symptomatic with fever, chills, cough, sore throat, and headacheMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-29 | Moderna | |
| 2 | 2021-01-26 | Moderna | |
| 3 | 2021-08-21 | Moderna | No |
| 4 | 2022-02-10 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2020-12-31 | priority 2/3 |
Free text
Release 1 — day 14, dose 1
Symptoms: Injection site swelled again with redness, warmth, and itching for 2 days
Release 9 — 6 months, dose 2
Symptoms: Miscarriage (early/chemical)
Release 9 — day 35, dose 3
Symptoms: Generalized myalgias
Release 9 — day 42, dose 3
Symptoms: Fatigue, evening muscle aches
Release 11 — 3 months, dose 4
Symptoms: Recently tested positive for Covid19, symptomatic with fever, chills, cough, sore throat, and headache
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | ✓ | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Injection site pruritus | ✓ | ✓ | ✓ |
| SD | Injection site swelling | ✓ | ✓ | ✓ |
| SD | Injection site warmth | ✓ | ✓ | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release